Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03292003 · ClinicalTrials.gov registry record
Journey II Bi-Cruciate Stabilized (BCS) Total Knee System Retrospective Study
A clinical trial of Total Knee Arthroplasty, sponsored by Smith & Nephew.
- Completed
- Registry status
- 1,694
- Enrollment target
- 12
- Study locations
NCT03292003: Completed study of Total Knee Arthroplasty, sponsored by Smith & Nephew.
NCT03292003 is a study of Total Knee Arthroplasty that has completed, run by Smith & Nephew. The registered enrollment target is 1,694 participants, above the 237-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (615% higher). The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03292003, a study of Total Knee Arthroplasty, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 1,694 participants
- Enrollment target
- 12
- Study locations
Study Summary
The objective of this study is to estimate the safety and performance of Journey II BCS TKS.
Primary Outcome
Number of revisions
Conditions Studied
Interventions
- DEVICE Journey II BCS Total Knee System
Study Locations (12)
Other
- Jesse Ziekenhuis - Hasselt
- UZ Leuven Campus - Pellenberg
- Christen Ortho AG - Bern
Colorado
- University of Colorado Orthopaedics - Aurora
Florida
- Andrews Research and Education Foundation - Gulf Breeze
Indiana
- Methodist Sports Medicine - Indianapolis
New York
- Hospital for Special Surgery - New York
Pennsylvania
- University Orthopaedics Center - State College
Tennessee
- TN Orthopaedic Foundation for Education and Research - Knoxville
Texas
- San Antonio Orthopaedic Specialists - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,694 participants |
| Start Date | 2016-12-30 |
| Est. Completion | 2018-09-24 |
What the finished NCT03292003 record still lists
NCT03292003 is an observational study that tracks outcomes without assigning an intervention. Its 1,694 participants enrollment target places it among the larger protocols in the corpus, above the 237-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (615% higher).
The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Journey II BCS Total Knee System is the first listed.
NCT03292003 lists 12 locations in 10 states (Other, Colorado, Florida).
Frequently Asked Questions
What is clinical trial NCT03292003 about?
NCT03292003 is a clinical study titled "Journey II Bi-Cruciate Stabilized (BCS) Total Knee System Retrospective Study". The objective of this study is to estimate the safety and performance of Journey II BCS TKS.
What is the current status of trial NCT03292003?
This trial is currently completed. The enrollment target is 1,694 participants. The study started on 2016-12-30. Estimated completion is 2018-09-24.
What conditions does trial NCT03292003 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty.
What interventions are being tested in trial NCT03292003?
The interventions under investigation include: Journey II BCS Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT03292003?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03292003 being conducted?
This trial has 12 study locations across Colorado, Florida, Indiana, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03292003's enrollment target sits among peer trials
1,694 2nd of 29 the highest of 29 other Total Knee Arthroplasty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraoperative VR for Older Patients Undergoing TKA
RECRUITING · NA
-
A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty
RECRUITING · Phase 4
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Medrol Dosepak for Outpatient Total Knee Arthroplasty
RECRUITING · Phase 4
-
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
RECRUITING · NA
-
Improving Rehabilitation for Veterans After Total Knee Arthroplasty Using Individualized Recovery Trajectories
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI